A Study of Venetoclax and Dinaciclib (MK7965) in Patients With Relapsed/Refractory Acute Myeloid Leukemia
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03484520 |
|
Recruitment Status :
Terminated
(Strategic considerations)
First Posted : March 30, 2018
Last Update Posted : December 30, 2022
|
Sponsor:
AbbVie
Collaborator:
Merck Sharp & Dohme LLC
Information provided by (Responsible Party):
AbbVie
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Terminated |
|---|---|
| Actual Primary Completion Date : | December 1, 2022 |
| Actual Study Completion Date : | December 1, 2022 |